Karamfilova V, Assyov Y, Nedeva I, Gateva A, Ivanova I, Cherkezov N, et al. Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease. Turkish Journal of Gastroenterology [Internet]. 2022 Jan. 3 [cited 2026 Jan. 1];33(3):233-9. Available from: https://www.turkjgastroenterol.org/index.php/tjg/article/view/3852